nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—Vinca Alkaloids—Vinorelbine—hematologic cancer	0.161	0.556	CiPCiCtD
Vinblastine—Vinca Alkaloids—Vincristine—hematologic cancer	0.128	0.444	CiPCiCtD
Vinblastine—Vinorelbine—hematologic cancer	0.122	0.556	CrCtD
Vinblastine—Vincristine—hematologic cancer	0.0974	0.444	CrCtD
Vinblastine—TUBB2A—hematologic cancer	0.0556	0.53	CbGaD
Vinblastine—JUN—hematologic cancer	0.0433	0.412	CbGaD
Vinblastine—Vindesine—Vinorelbine—hematologic cancer	0.0287	0.211	CrCrCtD
Vinblastine—Vincristine—Vinorelbine—hematologic cancer	0.0287	0.211	CrCrCtD
Vinblastine—Vinorelbine—Vincristine—hematologic cancer	0.0229	0.168	CrCrCtD
Vinblastine—Vindesine—Vincristine—hematologic cancer	0.0229	0.168	CrCrCtD
Vinblastine—Voacamine—Vinorelbine—hematologic cancer	0.0183	0.135	CrCrCtD
Vinblastine—NR5A1—Daunorubicin—hematologic cancer	0.0168	0.103	CbGbCtD
Vinblastine—Voacamine—Vincristine—hematologic cancer	0.0146	0.108	CrCrCtD
Vinblastine—NR5A1—Cladribine—hematologic cancer	0.014	0.0859	CbGbCtD
Vinblastine—ABCC6—Daunorubicin—hematologic cancer	0.0064	0.0394	CbGbCtD
Vinblastine—ABCB1—hematologic cancer	0.00606	0.0578	CbGaD
Vinblastine—ABCC6—Teniposide—hematologic cancer	0.00556	0.0342	CbGbCtD
Vinblastine—TUBB6—Vinorelbine—hematologic cancer	0.00528	0.0325	CbGbCtD
Vinblastine—TUBB2B—Vinorelbine—hematologic cancer	0.00528	0.0325	CbGbCtD
Vinblastine—TUBB4A—Vinorelbine—hematologic cancer	0.00528	0.0325	CbGbCtD
Vinblastine—TUBB3—Vinorelbine—hematologic cancer	0.00528	0.0325	CbGbCtD
Vinblastine—TUBB2A—Vinorelbine—hematologic cancer	0.00528	0.0325	CbGbCtD
Vinblastine—TUBB8—Vinorelbine—hematologic cancer	0.00528	0.0325	CbGbCtD
Vinblastine—TUBB1—Vinorelbine—hematologic cancer	0.00442	0.0272	CbGbCtD
Vinblastine—TUBB4B—Vinorelbine—hematologic cancer	0.00442	0.0272	CbGbCtD
Vinblastine—TUBB—Vinorelbine—hematologic cancer	0.00442	0.0272	CbGbCtD
Vinblastine—TUBB6—Vincristine—hematologic cancer	0.0032	0.0197	CbGbCtD
Vinblastine—TUBB8—Vincristine—hematologic cancer	0.0032	0.0197	CbGbCtD
Vinblastine—TUBB4A—Vincristine—hematologic cancer	0.0032	0.0197	CbGbCtD
Vinblastine—TUBB2B—Vincristine—hematologic cancer	0.0032	0.0197	CbGbCtD
Vinblastine—TUBB3—Vincristine—hematologic cancer	0.0032	0.0197	CbGbCtD
Vinblastine—TUBB2A—Vincristine—hematologic cancer	0.0032	0.0197	CbGbCtD
Vinblastine—NR5A1—ovarian follicle—hematologic cancer	0.003	0.173	CbGeAlD
Vinblastine—TUBB1—Vincristine—hematologic cancer	0.00268	0.0165	CbGbCtD
Vinblastine—TUBB4B—Vincristine—hematologic cancer	0.00268	0.0165	CbGbCtD
Vinblastine—TUBB—Vincristine—hematologic cancer	0.00268	0.0165	CbGbCtD
Vinblastine—ABCC1—Idarubicin—hematologic cancer	0.00267	0.0164	CbGbCtD
Vinblastine—ABCB11—Daunorubicin—hematologic cancer	0.00266	0.0163	CbGbCtD
Vinblastine—ABCC6—Cisplatin—hematologic cancer	0.0025	0.0154	CbGbCtD
Vinblastine—ABCC6—Etoposide—hematologic cancer	0.00245	0.0151	CbGbCtD
Vinblastine—ABCC1—Daunorubicin—hematologic cancer	0.00189	0.0116	CbGbCtD
Vinblastine—SLC22A2—Daunorubicin—hematologic cancer	0.00171	0.0105	CbGbCtD
Vinblastine—ABCC6—Doxorubicin—hematologic cancer	0.00167	0.0103	CbGbCtD
Vinblastine—SLC22A2—Cytarabine—hematologic cancer	0.00151	0.00929	CbGbCtD
Vinblastine—SLC22A2—Cladribine—hematologic cancer	0.00143	0.00877	CbGbCtD
Vinblastine—ABCC2—Daunorubicin—hematologic cancer	0.0014	0.0086	CbGbCtD
Vinblastine—SLC22A2—Imatinib—hematologic cancer	0.00131	0.00806	CbGbCtD
Vinblastine—ABCC1—Mitoxantrone—hematologic cancer	0.00115	0.00706	CbGbCtD
Vinblastine—ABCB11—Vincristine—hematologic cancer	0.00111	0.00684	CbGbCtD
Vinblastine—ABCC1—Epirubicin—hematologic cancer	0.000929	0.00571	CbGbCtD
Vinblastine—ABCC1—Irinotecan—hematologic cancer	0.000904	0.00556	CbGbCtD
Vinblastine—ABCB11—Dexamethasone—hematologic cancer	0.000838	0.00515	CbGbCtD
Vinblastine—ABCC1—Vincristine—hematologic cancer	0.00079	0.00486	CbGbCtD
Vinblastine—ABCB1—Lenalidomide—hematologic cancer	0.000777	0.00478	CbGbCtD
Vinblastine—ABCC1—Etoposide—hematologic cancer	0.000724	0.00445	CbGbCtD
Vinblastine—ABCB11—Doxorubicin—hematologic cancer	0.000695	0.00427	CbGbCtD
Vinblastine—CYP2D6—Lomustine—hematologic cancer	0.000681	0.00419	CbGbCtD
Vinblastine—ABCC2—Irinotecan—hematologic cancer	0.000669	0.00411	CbGbCtD
Vinblastine—SLC22A2—Cisplatin—hematologic cancer	0.000668	0.00411	CbGbCtD
Vinblastine—CYP2D6—Idarubicin—hematologic cancer	0.000607	0.00373	CbGbCtD
Vinblastine—ABCC2—Vincristine—hematologic cancer	0.000585	0.00359	CbGbCtD
Vinblastine—ABCC2—Cisplatin—hematologic cancer	0.000545	0.00335	CbGbCtD
Vinblastine—ABCC2—Etoposide—hematologic cancer	0.000536	0.00329	CbGbCtD
Vinblastine—CYP2D6—Hydroxyurea—hematologic cancer	0.000516	0.00317	CbGbCtD
Vinblastine—ABCC1—Doxorubicin—hematologic cancer	0.000494	0.00304	CbGbCtD
Vinblastine—ABCC1—Methotrexate—hematologic cancer	0.000478	0.00294	CbGbCtD
Vinblastine—CYP3A4—Bexarotene—hematologic cancer	0.000466	0.00286	CbGbCtD
Vinblastine—ABCB1—Daunorubicin—hematologic cancer	0.000456	0.0028	CbGbCtD
Vinblastine—CYP2D6—Bortezomib—hematologic cancer	0.000449	0.00276	CbGbCtD
Vinblastine—ABCB1—Alitretinoin—hematologic cancer	0.000446	0.00275	CbGbCtD
Vinblastine—ABCC2—Dexamethasone—hematologic cancer	0.00044	0.00271	CbGbCtD
Vinblastine—CYP3A4—Lomustine—hematologic cancer	0.000433	0.00266	CbGbCtD
Vinblastine—CYP3A4—Busulfan—hematologic cancer	0.000433	0.00266	CbGbCtD
Vinblastine—CYP3A4—Thiotepa—hematologic cancer	0.000386	0.00237	CbGbCtD
Vinblastine—TUBG1—hematopoietic system—hematologic cancer	0.000371	0.0214	CbGeAlD
Vinblastine—ABCC2—Doxorubicin—hematologic cancer	0.000365	0.00225	CbGbCtD
Vinblastine—NR5A1—hematopoietic system—hematologic cancer	0.000362	0.0209	CbGeAlD
Vinblastine—ABCC2—Methotrexate—hematologic cancer	0.000354	0.00218	CbGbCtD
Vinblastine—ABCB1—Imatinib—hematologic cancer	0.000349	0.00215	CbGbCtD
Vinblastine—CYP2D6—Imatinib—hematologic cancer	0.000329	0.00202	CbGbCtD
Vinblastine—ABCB1—Nilotinib—hematologic cancer	0.000317	0.00195	CbGbCtD
Vinblastine—TUBE1—gonad—hematologic cancer	0.000315	0.0182	CbGeAlD
Vinblastine—ABCB1—Vinorelbine—hematologic cancer	0.000315	0.00193	CbGbCtD
Vinblastine—TUBB3—hematopoietic system—hematologic cancer	0.000302	0.0174	CbGeAlD
Vinblastine—CYP3A4—Methoxsalen—hematologic cancer	0.0003	0.00185	CbGbCtD
Vinblastine—CYP2D6—Nilotinib—hematologic cancer	0.000299	0.00184	CbGbCtD
Vinblastine—CYP2D6—Vinorelbine—hematologic cancer	0.000296	0.00182	CbGbCtD
Vinblastine—TUBB1—hematopoietic system—hematologic cancer	0.000295	0.017	CbGeAlD
Vinblastine—TUBD1—blood—hematologic cancer	0.000293	0.0169	CbGeAlD
Vinblastine—CYP3A4—Bortezomib—hematologic cancer	0.000285	0.00176	CbGbCtD
Vinblastine—TUBD1—bone marrow—hematologic cancer	0.000283	0.0163	CbGeAlD
Vinblastine—TUBG1—gonad—hematologic cancer	0.000282	0.0163	CbGeAlD
Vinblastine—ABCB1—Dasatinib—hematologic cancer	0.00028	0.00172	CbGbCtD
Vinblastine—ABCB1—Mitoxantrone—hematologic cancer	0.000277	0.0017	CbGbCtD
Vinblastine—Vinorelbine—TUBB2A—hematologic cancer	0.000276	0.358	CrCbGaD
Vinblastine—NR5A1—gonad—hematologic cancer	0.000275	0.0159	CbGeAlD
Vinblastine—TUBE1—blood—hematologic cancer	0.000275	0.0158	CbGeAlD
Vinblastine—CYP3A4—Daunorubicin—hematologic cancer	0.000273	0.00168	CbGbCtD
Vinblastine—TUBE1—bone marrow—hematologic cancer	0.000266	0.0153	CbGeAlD
Vinblastine—TUBD1—lung—hematologic cancer	0.000257	0.0148	CbGeAlD
Vinblastine—ABCC6—hematopoietic system—hematologic cancer	0.000254	0.0146	CbGeAlD
Vinblastine—ABCB1—Betamethasone—hematologic cancer	0.000247	0.00152	CbGbCtD
Vinblastine—TUBG1—blood—hematologic cancer	0.000246	0.0142	CbGeAlD
Vinblastine—ABCB1—Gemcitabine—hematologic cancer	0.000245	0.0015	CbGbCtD
Vinblastine—ABCB1—Prednisolone—hematologic cancer	0.000244	0.0015	CbGbCtD
Vinblastine—TUBB8—testis—hematologic cancer	0.000242	0.014	CbGeAlD
Vinblastine—TUBD1—testis—hematologic cancer	0.000242	0.014	CbGeAlD
Vinblastine—CYP3A4—Cytarabine—hematologic cancer	0.000241	0.00148	CbGbCtD
Vinblastine—TUBE1—lung—hematologic cancer	0.000241	0.0139	CbGeAlD
Vinblastine—TUBG1—bone marrow—hematologic cancer	0.000238	0.0137	CbGeAlD
Vinblastine—CYP3A4—Teniposide—hematologic cancer	0.000237	0.00146	CbGbCtD
Vinblastine—ABCB1—Prednisone—hematologic cancer	0.00023	0.00141	CbGbCtD
Vinblastine—TUBE1—testis—hematologic cancer	0.000227	0.0131	CbGeAlD
Vinblastine—CYP3A4—Ifosfamide—hematologic cancer	0.000219	0.00135	CbGbCtD
Vinblastine—ABCB1—Irinotecan—hematologic cancer	0.000218	0.00134	CbGbCtD
Vinblastine—TUBG1—lung—hematologic cancer	0.000216	0.0124	CbGeAlD
Vinblastine—TUBA1A—hematopoietic system—hematologic cancer	0.000215	0.0124	CbGeAlD
Vinblastine—JUN—hematopoietic system—hematologic cancer	0.000213	0.0123	CbGeAlD
Vinblastine—Vincristine—TUBB2A—hematologic cancer	0.000209	0.271	CrCbGaD
Vinblastine—CYP3A4—Imatinib—hematologic cancer	0.000209	0.00129	CbGbCtD
Vinblastine—TUBG1—testis—hematologic cancer	0.000203	0.0117	CbGeAlD
Vinblastine—TUBB3—blood—hematologic cancer	0.0002	0.0115	CbGeAlD
Vinblastine—NR5A1—testis—hematologic cancer	0.000198	0.0114	CbGeAlD
Vinblastine—CYP3A4—Ruxolitinib—hematologic cancer	0.000197	0.00121	CbGbCtD
Vinblastine—TUBB1—blood—hematologic cancer	0.000195	0.0113	CbGeAlD
Vinblastine—ABCB1—Vincristine—hematologic cancer	0.000191	0.00117	CbGbCtD
Vinblastine—CYP3A4—Nilotinib—hematologic cancer	0.00019	0.00117	CbGbCtD
Vinblastine—TUBB1—bone marrow—hematologic cancer	0.000189	0.0109	CbGeAlD
Vinblastine—CYP3A4—Vinorelbine—hematologic cancer	0.000188	0.00116	CbGbCtD
Vinblastine—TUBB4A—hematopoietic system—hematologic cancer	0.000184	0.0106	CbGeAlD
Vinblastine—ABCB1—Cisplatin—hematologic cancer	0.000178	0.00109	CbGbCtD
Vinblastine—TUBD1—lymph node—hematologic cancer	0.000176	0.0101	CbGeAlD
Vinblastine—TUBB3—lung—hematologic cancer	0.000175	0.0101	CbGeAlD
Vinblastine—ABCB1—Etoposide—hematologic cancer	0.000175	0.00107	CbGbCtD
Vinblastine—CYP3A4—Triamcinolone—hematologic cancer	0.000172	0.00106	CbGbCtD
Vinblastine—ABCC6—blood—hematologic cancer	0.000168	0.0097	CbGeAlD
Vinblastine—CYP3A4—Dasatinib—hematologic cancer	0.000168	0.00103	CbGbCtD
Vinblastine—TUBB2A—hematopoietic system—hematologic cancer	0.000167	0.00963	CbGeAlD
Vinblastine—CYP3A4—Mitoxantrone—hematologic cancer	0.000166	0.00102	CbGbCtD
Vinblastine—TUBB3—testis—hematologic cancer	0.000165	0.00953	CbGeAlD
Vinblastine—TUBB6—hematopoietic system—hematologic cancer	0.000165	0.0095	CbGeAlD
Vinblastine—TUBE1—lymph node—hematologic cancer	0.000165	0.00949	CbGeAlD
Vinblastine—TUBA1A—gonad—hematologic cancer	0.000163	0.00942	CbGeAlD
Vinblastine—JUN—gonad—hematologic cancer	0.000162	0.00933	CbGeAlD
Vinblastine—TUBB1—testis—hematologic cancer	0.000162	0.00932	CbGeAlD
Vinblastine—CYP3A4—Betamethasone—hematologic cancer	0.000148	0.000909	CbGbCtD
Vinblastine—ABCC6—lung—hematologic cancer	0.000147	0.0085	CbGeAlD
Vinblastine—TUBG1—lymph node—hematologic cancer	0.000147	0.0085	CbGeAlD
Vinblastine—CYP3A4—Prednisolone—hematologic cancer	0.000146	0.000897	CbGbCtD
Vinblastine—ABCB1—Dexamethasone—hematologic cancer	0.000144	0.000883	CbGbCtD
Vinblastine—TUBB4B—hematopoietic system—hematologic cancer	0.000143	0.00826	CbGeAlD
Vinblastine—TUBA1A—blood—hematologic cancer	0.000142	0.00821	CbGeAlD
Vinblastine—JUN—blood—hematologic cancer	0.000141	0.00813	CbGeAlD
Vinblastine—TUBB4A—gonad—hematologic cancer	0.00014	0.00805	CbGeAlD
Vinblastine—CYP3A4—Prednisone—hematologic cancer	0.000138	0.000847	CbGbCtD
Vinblastine—TUBA1A—bone marrow—hematologic cancer	0.000138	0.00794	CbGeAlD
Vinblastine—JUN—bone marrow—hematologic cancer	0.000136	0.00786	CbGeAlD
Vinblastine—CYP2D6—Dexamethasone—hematologic cancer	0.000135	0.000832	CbGbCtD
Vinblastine—TUBB2B—gonad—hematologic cancer	0.000135	0.00778	CbGeAlD
Vinblastine—CYP3A4—Irinotecan—hematologic cancer	0.000131	0.000803	CbGbCtD
Vinblastine—TUBB6—gonad—hematologic cancer	0.000125	0.00722	CbGeAlD
Vinblastine—ABCB11—testis—hematologic cancer	0.000125	0.0072	CbGeAlD
Vinblastine—TUBA1A—lung—hematologic cancer	0.000125	0.00719	CbGeAlD
Vinblastine—JUN—lung—hematologic cancer	0.000124	0.00712	CbGeAlD
Vinblastine—TUBB4A—blood—hematologic cancer	0.000122	0.00701	CbGeAlD
Vinblastine—ABCB1—Doxorubicin—hematologic cancer	0.000119	0.000732	CbGbCtD
Vinblastine—TUBA1A—testis—hematologic cancer	0.000118	0.00679	CbGeAlD
Vinblastine—JUN—testis—hematologic cancer	0.000117	0.00672	CbGeAlD
Vinblastine—ABCB1—Methotrexate—hematologic cancer	0.000115	0.000709	CbGbCtD
Vinblastine—CYP3A4—Vincristine—hematologic cancer	0.000114	0.000702	CbGbCtD
Vinblastine—Vincristine—ABCC3—hematologic cancer	0.000113	0.146	CrCbGaD
Vinblastine—CYP2D6—Doxorubicin—hematologic cancer	0.000112	0.00069	CbGbCtD
Vinblastine—TUBB—blood—hematologic cancer	0.000111	0.00641	CbGeAlD
Vinblastine—TUBB2A—blood—hematologic cancer	0.000111	0.00638	CbGeAlD
Vinblastine—TUBB6—blood—hematologic cancer	0.000109	0.00629	CbGeAlD
Vinblastine—TUBB4B—gonad—hematologic cancer	0.000109	0.00628	CbGeAlD
Vinblastine—TUBB—bone marrow—hematologic cancer	0.000108	0.00621	CbGeAlD
Vinblastine—TUBB2A—bone marrow—hematologic cancer	0.000107	0.00617	CbGeAlD
Vinblastine—TUBB4A—lung—hematologic cancer	0.000107	0.00615	CbGeAlD
Vinblastine—TUBB6—bone marrow—hematologic cancer	0.000106	0.00609	CbGeAlD
Vinblastine—CYP3A4—Etoposide—hematologic cancer	0.000105	0.000643	CbGbCtD
Vinblastine—TUBB2B—lung—hematologic cancer	0.000103	0.00594	CbGeAlD
Vinblastine—TUBB4A—testis—hematologic cancer	0.000101	0.0058	CbGeAlD
Vinblastine—TUBB—lung—hematologic cancer	9.75e-05	0.00562	CbGeAlD
Vinblastine—TUBB2B—testis—hematologic cancer	9.72e-05	0.00561	CbGeAlD
Vinblastine—TUBB2A—lung—hematologic cancer	9.7e-05	0.00559	CbGeAlD
Vinblastine—TUBB6—lung—hematologic cancer	9.57e-05	0.00552	CbGeAlD
Vinblastine—TUBB4B—blood—hematologic cancer	9.49e-05	0.00547	CbGeAlD
Vinblastine—TUBB—testis—hematologic cancer	9.2e-05	0.00531	CbGeAlD
Vinblastine—TUBB4B—bone marrow—hematologic cancer	9.18e-05	0.00529	CbGeAlD
Vinblastine—TUBB2A—testis—hematologic cancer	9.15e-05	0.00528	CbGeAlD
Vinblastine—TUBB6—testis—hematologic cancer	9.03e-05	0.0052	CbGeAlD
Vinblastine—CYP3A4—Dexamethasone—hematologic cancer	8.6e-05	0.000529	CbGbCtD
Vinblastine—TUBA1A—lymph node—hematologic cancer	8.53e-05	0.00492	CbGeAlD
Vinblastine—JUN—lymph node—hematologic cancer	8.45e-05	0.00487	CbGeAlD
Vinblastine—TUBB4B—lung—hematologic cancer	8.32e-05	0.00479	CbGeAlD
Vinblastine—TUBB4B—testis—hematologic cancer	7.85e-05	0.00452	CbGeAlD
Vinblastine—ABCC2—blood—hematologic cancer	7.67e-05	0.00442	CbGeAlD
Vinblastine—TUBB4A—lymph node—hematologic cancer	7.29e-05	0.0042	CbGeAlD
Vinblastine—CYP3A4—Doxorubicin—hematologic cancer	7.14e-05	0.000439	CbGbCtD
Vinblastine—TUBB2B—lymph node—hematologic cancer	7.05e-05	0.00406	CbGeAlD
Vinblastine—TUBA1A—Vitamin A—Alitretinoin—hematologic cancer	7.03e-05	0.0871	CbGdCrCtD
Vinblastine—ABCC1—blood—hematologic cancer	6.76e-05	0.0039	CbGeAlD
Vinblastine—TUBB—lymph node—hematologic cancer	6.67e-05	0.00385	CbGeAlD
Vinblastine—TUBB2A—lymph node—hematologic cancer	6.64e-05	0.00383	CbGeAlD
Vinblastine—ABCC6—Podofilox—Teniposide—hematologic cancer	6.59e-05	0.0816	CbGdCrCtD
Vinblastine—TUBB6—lymph node—hematologic cancer	6.54e-05	0.00377	CbGeAlD
Vinblastine—Voacamine—ABCB1—hematologic cancer	6.5e-05	0.0843	CrCbGaD
Vinblastine—ABCC2—testis—hematologic cancer	6.35e-05	0.00366	CbGeAlD
Vinblastine—ABCC1—lung—hematologic cancer	5.93e-05	0.00342	CbGeAlD
Vinblastine—CYP3A4—hematopoietic system—hematologic cancer	5.88e-05	0.00339	CbGeAlD
Vinblastine—CYP2D6—hematopoietic system—hematologic cancer	5.79e-05	0.00334	CbGeAlD
Vinblastine—TUBB4B—lymph node—hematologic cancer	5.69e-05	0.00328	CbGeAlD
Vinblastine—ABCC1—testis—hematologic cancer	5.59e-05	0.00322	CbGeAlD
Vinblastine—TUBA1A—Zalcitabine—Gemcitabine—hematologic cancer	5.58e-05	0.0692	CbGdCrCtD
Vinblastine—TUBA1A—Zalcitabine—Cytarabine—hematologic cancer	5.58e-05	0.0692	CbGdCrCtD
Vinblastine—Vincristine—ABCG2—hematologic cancer	5.48e-05	0.0711	CrCbGaD
Vinblastine—TUBA1A—Isotretinoin—Alitretinoin—hematologic cancer	4.91e-05	0.0609	CbGdCrCtD
Vinblastine—TUBA1A—Tretinoin—Alitretinoin—hematologic cancer	4.91e-05	0.0609	CbGdCrCtD
Vinblastine—ABCC2—lymph node—hematologic cancer	4.6e-05	0.00265	CbGeAlD
Vinblastine—ABCB1—hematopoietic system—hematologic cancer	4.16e-05	0.0024	CbGeAlD
Vinblastine—ABCC1—lymph node—hematologic cancer	4.05e-05	0.00234	CbGeAlD
Vinblastine—ABCC6—Podofilox—Etoposide—hematologic cancer	3.92e-05	0.0485	CbGdCrCtD
Vinblastine—CYP3A4—blood—hematologic cancer	3.9e-05	0.00225	CbGeAlD
Vinblastine—CYP2D6—blood—hematologic cancer	3.84e-05	0.00221	CbGeAlD
Vinblastine—TUBB—Menadione—Thalidomide—hematologic cancer	3.46e-05	0.0429	CbGdCrCtD
Vinblastine—CYP2D6—testis—hematologic cancer	3.17e-05	0.00183	CbGeAlD
Vinblastine—ABCB1—gonad—hematologic cancer	3.17e-05	0.00183	CbGeAlD
Vinblastine—Vinorelbine—ABCB1—hematologic cancer	3.01e-05	0.039	CrCbGaD
Vinblastine—ABCB1—blood—hematologic cancer	2.76e-05	0.00159	CbGeAlD
Vinblastine—TUBB6—Vitamin A—Alitretinoin—hematologic cancer	2.71e-05	0.0335	CbGdCrCtD
Vinblastine—ABCB1—bone marrow—hematologic cancer	2.67e-05	0.00154	CbGeAlD
Vinblastine—ABCB1—lung—hematologic cancer	2.42e-05	0.00139	CbGeAlD
Vinblastine—ABCB1—testis—hematologic cancer	2.28e-05	0.00132	CbGeAlD
Vinblastine—Vincristine—ABCB1—hematologic cancer	2.28e-05	0.0296	CrCbGaD
Vinblastine—TUBB6—Zalcitabine—Cytarabine—hematologic cancer	2.15e-05	0.0267	CbGdCrCtD
Vinblastine—TUBB6—Zalcitabine—Gemcitabine—hematologic cancer	2.15e-05	0.0267	CbGdCrCtD
Vinblastine—TUBA1A—Azacitidine—Pentostatin—hematologic cancer	1.9e-05	0.0235	CbGdCrCtD
Vinblastine—TUBB6—Tretinoin—Alitretinoin—hematologic cancer	1.89e-05	0.0234	CbGdCrCtD
Vinblastine—TUBB6—Isotretinoin—Alitretinoin—hematologic cancer	1.89e-05	0.0234	CbGdCrCtD
Vinblastine—TUBB—Azacitidine—Pentostatin—hematologic cancer	1.77e-05	0.022	CbGdCrCtD
Vinblastine—TUBA1A—Azacitidine—Clofarabine—hematologic cancer	1.69e-05	0.021	CbGdCrCtD
Vinblastine—ABCB1—lymph node—hematologic cancer	1.65e-05	0.000954	CbGeAlD
Vinblastine—TUBA1A—Azacitidine—Nelarabine—hematologic cancer	1.59e-05	0.0197	CbGdCrCtD
Vinblastine—TUBB—Azacitidine—Clofarabine—hematologic cancer	1.58e-05	0.0196	CbGdCrCtD
Vinblastine—TUBB—Azacitidine—Nelarabine—hematologic cancer	1.49e-05	0.0184	CbGdCrCtD
Vinblastine—TUBA1A—Azacitidine—Fludarabine—hematologic cancer	1.24e-05	0.0154	CbGdCrCtD
Vinblastine—TUBA1A—Azacitidine—Cytarabine—hematologic cancer	1.17e-05	0.0145	CbGdCrCtD
Vinblastine—TUBA1A—Azacitidine—Gemcitabine—hematologic cancer	1.17e-05	0.0145	CbGdCrCtD
Vinblastine—TUBB—Azacitidine—Fludarabine—hematologic cancer	1.16e-05	0.0144	CbGdCrCtD
Vinblastine—TUBA1A—Azacitidine—Cladribine—hematologic cancer	1.14e-05	0.0142	CbGdCrCtD
Vinblastine—TUBB—Azacitidine—Gemcitabine—hematologic cancer	1.09e-05	0.0136	CbGdCrCtD
Vinblastine—TUBB—Azacitidine—Cytarabine—hematologic cancer	1.09e-05	0.0136	CbGdCrCtD
Vinblastine—TUBB—Azacitidine—Cladribine—hematologic cancer	1.07e-05	0.0132	CbGdCrCtD
Vinblastine—Pancytopenia—Epirubicin—hematologic cancer	1.01e-05	0.000268	CcSEcCtD
Vinblastine—Ill-defined disorder—Betamethasone—hematologic cancer	1.01e-05	0.000268	CcSEcCtD
Vinblastine—Ill-defined disorder—Dexamethasone—hematologic cancer	1.01e-05	0.000268	CcSEcCtD
Vinblastine—Headache—Bortezomib—hematologic cancer	1.01e-05	0.000267	CcSEcCtD
Vinblastine—Discomfort—Triamcinolone—hematologic cancer	1.01e-05	0.000267	CcSEcCtD
Vinblastine—Pain—Cisplatin—hematologic cancer	1.01e-05	0.000267	CcSEcCtD
Vinblastine—Hypersensitivity—Ifosfamide—hematologic cancer	1.01e-05	0.000267	CcSEcCtD
Vinblastine—Asthenia—Carmustine—hematologic cancer	1e-05	0.000265	CcSEcCtD
Vinblastine—Vomiting—Vinorelbine—hematologic cancer	1e-05	0.000265	CcSEcCtD
Vinblastine—Diarrhoea—Thalidomide—hematologic cancer	9.97e-06	0.000263	CcSEcCtD
Vinblastine—Dizziness—Thiotepa—hematologic cancer	9.96e-06	0.000263	CcSEcCtD
Vinblastine—Asthenia—Alitretinoin—hematologic cancer	9.94e-06	0.000263	CcSEcCtD
Vinblastine—Headache—Vinorelbine—hematologic cancer	9.88e-06	0.000261	CcSEcCtD
Vinblastine—Hypersensitivity—Vincristine—hematologic cancer	9.84e-06	0.00026	CcSEcCtD
Vinblastine—Malaise—Dexamethasone—hematologic cancer	9.84e-06	0.00026	CcSEcCtD
Vinblastine—Malaise—Betamethasone—hematologic cancer	9.84e-06	0.00026	CcSEcCtD
Vinblastine—Asthenia—Ifosfamide—hematologic cancer	9.83e-06	0.00026	CcSEcCtD
Vinblastine—Vertigo—Betamethasone—hematologic cancer	9.8e-06	0.000259	CcSEcCtD
Vinblastine—Vertigo—Dexamethasone—hematologic cancer	9.8e-06	0.000259	CcSEcCtD
Vinblastine—Feeling abnormal—Cisplatin—hematologic cancer	9.73e-06	0.000257	CcSEcCtD
Vinblastine—Paraesthesia—Etoposide—hematologic cancer	9.72e-06	0.000257	CcSEcCtD
Vinblastine—Alopecia—Prednisone—hematologic cancer	9.64e-06	0.000255	CcSEcCtD
Vinblastine—Dizziness—Thalidomide—hematologic cancer	9.63e-06	0.000255	CcSEcCtD
Vinblastine—Angina pectoris—Doxorubicin—hematologic cancer	9.61e-06	0.000254	CcSEcCtD
Vinblastine—Nausea—Bortezomib—hematologic cancer	9.59e-06	0.000254	CcSEcCtD
Vinblastine—Hypersensitivity—Irinotecan—hematologic cancer	9.58e-06	0.000253	CcSEcCtD
Vinblastine—Hypersensitivity—Mitoxantrone—hematologic cancer	9.58e-06	0.000253	CcSEcCtD
Vinblastine—Asthenia—Vincristine—hematologic cancer	9.58e-06	0.000253	CcSEcCtD
Vinblastine—Paraesthesia—Prednisolone—hematologic cancer	9.58e-06	0.000253	CcSEcCtD
Vinblastine—Vomiting—Thiotepa—hematologic cancer	9.58e-06	0.000253	CcSEcCtD
Vinblastine—Diarrhoea—Carmustine—hematologic cancer	9.57e-06	0.000253	CcSEcCtD
Vinblastine—Nausea—Bleomycin—hematologic cancer	9.52e-06	0.000252	CcSEcCtD
Vinblastine—Diarrhoea—Alitretinoin—hematologic cancer	9.48e-06	0.000251	CcSEcCtD
Vinblastine—Agranulocytosis—Methotrexate—hematologic cancer	9.48e-06	0.000251	CcSEcCtD
Vinblastine—Convulsion—Betamethasone—hematologic cancer	9.45e-06	0.00025	CcSEcCtD
Vinblastine—Convulsion—Dexamethasone—hematologic cancer	9.45e-06	0.00025	CcSEcCtD
Vinblastine—Headache—Thiotepa—hematologic cancer	9.44e-06	0.000249	CcSEcCtD
Vinblastine—Hypertension—Betamethasone—hematologic cancer	9.42e-06	0.000249	CcSEcCtD
Vinblastine—Hypertension—Dexamethasone—hematologic cancer	9.42e-06	0.000249	CcSEcCtD
Vinblastine—Decreased appetite—Etoposide—hematologic cancer	9.41e-06	0.000249	CcSEcCtD
Vinblastine—Diarrhoea—Ifosfamide—hematologic cancer	9.37e-06	0.000248	CcSEcCtD
Vinblastine—Pancytopenia—Doxorubicin—hematologic cancer	9.37e-06	0.000248	CcSEcCtD
Vinblastine—Nausea—Vinorelbine—hematologic cancer	9.37e-06	0.000248	CcSEcCtD
Vinblastine—Asthenia—Irinotecan—hematologic cancer	9.33e-06	0.000247	CcSEcCtD
Vinblastine—Asthenia—Mitoxantrone—hematologic cancer	9.33e-06	0.000247	CcSEcCtD
Vinblastine—Neuropathy peripheral—Epirubicin—hematologic cancer	9.32e-06	0.000246	CcSEcCtD
Vinblastine—Vomiting—Thalidomide—hematologic cancer	9.26e-06	0.000245	CcSEcCtD
Vinblastine—Dizziness—Carmustine—hematologic cancer	9.25e-06	0.000245	CcSEcCtD
Vinblastine—Constipation—Etoposide—hematologic cancer	9.25e-06	0.000245	CcSEcCtD
Vinblastine—Pain—Etoposide—hematologic cancer	9.25e-06	0.000245	CcSEcCtD
Vinblastine—Discomfort—Betamethasone—hematologic cancer	9.18e-06	0.000243	CcSEcCtD
Vinblastine—Discomfort—Dexamethasone—hematologic cancer	9.18e-06	0.000243	CcSEcCtD
Vinblastine—Haemoglobin—Methotrexate—hematologic cancer	9.17e-06	0.000242	CcSEcCtD
Vinblastine—Dizziness—Alitretinoin—hematologic cancer	9.17e-06	0.000242	CcSEcCtD
Vinblastine—Diarrhoea—Vincristine—hematologic cancer	9.14e-06	0.000242	CcSEcCtD
Vinblastine—Headache—Thalidomide—hematologic cancer	9.13e-06	0.000241	CcSEcCtD
Vinblastine—Pain—Prednisolone—hematologic cancer	9.13e-06	0.000241	CcSEcCtD
Vinblastine—Haemorrhage—Methotrexate—hematologic cancer	9.12e-06	0.000241	CcSEcCtD
Vinblastine—Asthenia—Gemcitabine—hematologic cancer	9.09e-06	0.00024	CcSEcCtD
Vinblastine—Dizziness—Ifosfamide—hematologic cancer	9.06e-06	0.000239	CcSEcCtD
Vinblastine—Pharyngitis—Methotrexate—hematologic cancer	9.05e-06	0.000239	CcSEcCtD
Vinblastine—Nausea—Thiotepa—hematologic cancer	8.95e-06	0.000236	CcSEcCtD
Vinblastine—Feeling abnormal—Etoposide—hematologic cancer	8.92e-06	0.000236	CcSEcCtD
Vinblastine—Diarrhoea—Irinotecan—hematologic cancer	8.9e-06	0.000235	CcSEcCtD
Vinblastine—Diarrhoea—Mitoxantrone—hematologic cancer	8.9e-06	0.000235	CcSEcCtD
Vinblastine—Vomiting—Carmustine—hematologic cancer	8.9e-06	0.000235	CcSEcCtD
Vinblastine—Agranulocytosis—Epirubicin—hematologic cancer	8.87e-06	0.000235	CcSEcCtD
Vinblastine—Gastrointestinal pain—Etoposide—hematologic cancer	8.85e-06	0.000234	CcSEcCtD
Vinblastine—Dizziness—Vincristine—hematologic cancer	8.83e-06	0.000233	CcSEcCtD
Vinblastine—Ill-defined disorder—Prednisone—hematologic cancer	8.82e-06	0.000233	CcSEcCtD
Vinblastine—Vomiting—Alitretinoin—hematologic cancer	8.81e-06	0.000233	CcSEcCtD
Vinblastine—Paraesthesia—Triamcinolone—hematologic cancer	8.81e-06	0.000233	CcSEcCtD
Vinblastine—Feeling abnormal—Prednisolone—hematologic cancer	8.79e-06	0.000232	CcSEcCtD
Vinblastine—Anaemia—Prednisone—hematologic cancer	8.78e-06	0.000232	CcSEcCtD
Vinblastine—Headache—Carmustine—hematologic cancer	8.76e-06	0.000232	CcSEcCtD
Vinblastine—Thrombocytopenia—Dexamethasone—hematologic cancer	8.72e-06	0.00023	CcSEcCtD
Vinblastine—Thrombocytopenia—Betamethasone—hematologic cancer	8.72e-06	0.00023	CcSEcCtD
Vinblastine—Vomiting—Ifosfamide—hematologic cancer	8.71e-06	0.00023	CcSEcCtD
Vinblastine—Hypersensitivity—Cisplatin—hematologic cancer	8.7e-06	0.00023	CcSEcCtD
Vinblastine—Headache—Alitretinoin—hematologic cancer	8.68e-06	0.00023	CcSEcCtD
Vinblastine—Diarrhoea—Gemcitabine—hematologic cancer	8.67e-06	0.000229	CcSEcCtD
Vinblastine—Nausea—Thalidomide—hematologic cancer	8.65e-06	0.000229	CcSEcCtD
Vinblastine—Neuropathy peripheral—Doxorubicin—hematologic cancer	8.62e-06	0.000228	CcSEcCtD
Vinblastine—Dizziness—Irinotecan—hematologic cancer	8.6e-06	0.000227	CcSEcCtD
Vinblastine—Haemoglobin—Epirubicin—hematologic cancer	8.58e-06	0.000227	CcSEcCtD
Vinblastine—Malaise—Prednisone—hematologic cancer	8.57e-06	0.000226	CcSEcCtD
Vinblastine—Abdominal pain—Etoposide—hematologic cancer	8.55e-06	0.000226	CcSEcCtD
Vinblastine—Vertigo—Prednisone—hematologic cancer	8.54e-06	0.000226	CcSEcCtD
Vinblastine—Haemorrhage—Epirubicin—hematologic cancer	8.54e-06	0.000226	CcSEcCtD
Vinblastine—Hypoaesthesia—Epirubicin—hematologic cancer	8.49e-06	0.000224	CcSEcCtD
Vinblastine—Vomiting—Vincristine—hematologic cancer	8.49e-06	0.000224	CcSEcCtD
Vinblastine—Anorexia—Dexamethasone—hematologic cancer	8.49e-06	0.000224	CcSEcCtD
Vinblastine—Anorexia—Betamethasone—hematologic cancer	8.49e-06	0.000224	CcSEcCtD
Vinblastine—Asthenia—Cisplatin—hematologic cancer	8.47e-06	0.000224	CcSEcCtD
Vinblastine—Pharyngitis—Epirubicin—hematologic cancer	8.47e-06	0.000224	CcSEcCtD
Vinblastine—Pain—Triamcinolone—hematologic cancer	8.39e-06	0.000222	CcSEcCtD
Vinblastine—Headache—Vincristine—hematologic cancer	8.37e-06	0.000221	CcSEcCtD
Vinblastine—Nausea—Carmustine—hematologic cancer	8.31e-06	0.00022	CcSEcCtD
Vinblastine—Vomiting—Irinotecan—hematologic cancer	8.27e-06	0.000219	CcSEcCtD
Vinblastine—Vomiting—Mitoxantrone—hematologic cancer	8.27e-06	0.000219	CcSEcCtD
Vinblastine—Nausea—Alitretinoin—hematologic cancer	8.23e-06	0.000218	CcSEcCtD
Vinblastine—Convulsion—Prednisone—hematologic cancer	8.23e-06	0.000218	CcSEcCtD
Vinblastine—Agranulocytosis—Doxorubicin—hematologic cancer	8.21e-06	0.000217	CcSEcCtD
Vinblastine—Hypertension—Prednisone—hematologic cancer	8.2e-06	0.000217	CcSEcCtD
Vinblastine—Headache—Mitoxantrone—hematologic cancer	8.15e-06	0.000215	CcSEcCtD
Vinblastine—Headache—Irinotecan—hematologic cancer	8.15e-06	0.000215	CcSEcCtD
Vinblastine—Nausea—Ifosfamide—hematologic cancer	8.14e-06	0.000215	CcSEcCtD
Vinblastine—Feeling abnormal—Triamcinolone—hematologic cancer	8.09e-06	0.000214	CcSEcCtD
Vinblastine—Diarrhoea—Cisplatin—hematologic cancer	8.08e-06	0.000214	CcSEcCtD
Vinblastine—Alopecia—Methotrexate—hematologic cancer	8.06e-06	0.000213	CcSEcCtD
Vinblastine—Vomiting—Gemcitabine—hematologic cancer	8.06e-06	0.000213	CcSEcCtD
Vinblastine—Paraesthesia—Betamethasone—hematologic cancer	8e-06	0.000211	CcSEcCtD
Vinblastine—Paraesthesia—Dexamethasone—hematologic cancer	8e-06	0.000211	CcSEcCtD
Vinblastine—Discomfort—Prednisone—hematologic cancer	7.99e-06	0.000211	CcSEcCtD
Vinblastine—Hypersensitivity—Etoposide—hematologic cancer	7.97e-06	0.000211	CcSEcCtD
Vinblastine—Haemoglobin—Doxorubicin—hematologic cancer	7.94e-06	0.00021	CcSEcCtD
Vinblastine—Headache—Gemcitabine—hematologic cancer	7.94e-06	0.00021	CcSEcCtD
Vinblastine—Nausea—Vincristine—hematologic cancer	7.93e-06	0.00021	CcSEcCtD
Vinblastine—Haemorrhage—Doxorubicin—hematologic cancer	7.9e-06	0.000209	CcSEcCtD
Vinblastine—Hypersensitivity—Prednisolone—hematologic cancer	7.86e-06	0.000208	CcSEcCtD
Vinblastine—Hypoaesthesia—Doxorubicin—hematologic cancer	7.86e-06	0.000208	CcSEcCtD
Vinblastine—Pharyngitis—Doxorubicin—hematologic cancer	7.84e-06	0.000207	CcSEcCtD
Vinblastine—Asthenia—Etoposide—hematologic cancer	7.76e-06	0.000205	CcSEcCtD
Vinblastine—Decreased appetite—Dexamethasone—hematologic cancer	7.74e-06	0.000205	CcSEcCtD
Vinblastine—Decreased appetite—Betamethasone—hematologic cancer	7.74e-06	0.000205	CcSEcCtD
Vinblastine—Nausea—Mitoxantrone—hematologic cancer	7.73e-06	0.000204	CcSEcCtD
Vinblastine—Nausea—Irinotecan—hematologic cancer	7.73e-06	0.000204	CcSEcCtD
Vinblastine—Pain—Dexamethasone—hematologic cancer	7.61e-06	0.000201	CcSEcCtD
Vinblastine—Pain—Betamethasone—hematologic cancer	7.61e-06	0.000201	CcSEcCtD
Vinblastine—Alopecia—Epirubicin—hematologic cancer	7.54e-06	0.000199	CcSEcCtD
Vinblastine—Nausea—Gemcitabine—hematologic cancer	7.53e-06	0.000199	CcSEcCtD
Vinblastine—Vomiting—Cisplatin—hematologic cancer	7.51e-06	0.000198	CcSEcCtD
Vinblastine—Diarrhoea—Etoposide—hematologic cancer	7.4e-06	0.000196	CcSEcCtD
Vinblastine—Anorexia—Prednisone—hematologic cancer	7.39e-06	0.000195	CcSEcCtD
Vinblastine—Ill-defined disorder—Methotrexate—hematologic cancer	7.37e-06	0.000195	CcSEcCtD
Vinblastine—Anaemia—Methotrexate—hematologic cancer	7.34e-06	0.000194	CcSEcCtD
Vinblastine—Feeling abnormal—Dexamethasone—hematologic cancer	7.34e-06	0.000194	CcSEcCtD
Vinblastine—Feeling abnormal—Betamethasone—hematologic cancer	7.34e-06	0.000194	CcSEcCtD
Vinblastine—TUBB6—Azacitidine—Pentostatin—hematologic cancer	7.32e-06	0.00907	CbGdCrCtD
Vinblastine—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.28e-06	0.000192	CcSEcCtD
Vinblastine—Gastrointestinal pain—Betamethasone—hematologic cancer	7.28e-06	0.000192	CcSEcCtD
Vinblastine—Hypersensitivity—Triamcinolone—hematologic cancer	7.23e-06	0.000191	CcSEcCtD
Vinblastine—Malaise—Methotrexate—hematologic cancer	7.16e-06	0.000189	CcSEcCtD
Vinblastine—Dizziness—Etoposide—hematologic cancer	7.15e-06	0.000189	CcSEcCtD
Vinblastine—Vertigo—Methotrexate—hematologic cancer	7.13e-06	0.000189	CcSEcCtD
Vinblastine—Leukopenia—Methotrexate—hematologic cancer	7.11e-06	0.000188	CcSEcCtD
Vinblastine—Dizziness—Prednisolone—hematologic cancer	7.06e-06	0.000187	CcSEcCtD
Vinblastine—Asthenia—Triamcinolone—hematologic cancer	7.04e-06	0.000186	CcSEcCtD
Vinblastine—Abdominal pain—Betamethasone—hematologic cancer	7.04e-06	0.000186	CcSEcCtD
Vinblastine—Abdominal pain—Dexamethasone—hematologic cancer	7.04e-06	0.000186	CcSEcCtD
Vinblastine—Nausea—Cisplatin—hematologic cancer	7.01e-06	0.000185	CcSEcCtD
Vinblastine—Alopecia—Doxorubicin—hematologic cancer	6.98e-06	0.000184	CcSEcCtD
Vinblastine—Paraesthesia—Prednisone—hematologic cancer	6.96e-06	0.000184	CcSEcCtD
Vinblastine—Ill-defined disorder—Epirubicin—hematologic cancer	6.89e-06	0.000182	CcSEcCtD
Vinblastine—Convulsion—Methotrexate—hematologic cancer	6.88e-06	0.000182	CcSEcCtD
Vinblastine—Vomiting—Etoposide—hematologic cancer	6.88e-06	0.000182	CcSEcCtD
Vinblastine—Anaemia—Epirubicin—hematologic cancer	6.87e-06	0.000182	CcSEcCtD
Vinblastine—Headache—Etoposide—hematologic cancer	6.78e-06	0.000179	CcSEcCtD
Vinblastine—Decreased appetite—Prednisone—hematologic cancer	6.74e-06	0.000178	CcSEcCtD
Vinblastine—Malaise—Epirubicin—hematologic cancer	6.7e-06	0.000177	CcSEcCtD
Vinblastine—Headache—Prednisolone—hematologic cancer	6.69e-06	0.000177	CcSEcCtD
Vinblastine—Discomfort—Methotrexate—hematologic cancer	6.68e-06	0.000177	CcSEcCtD
Vinblastine—Vertigo—Epirubicin—hematologic cancer	6.68e-06	0.000176	CcSEcCtD
Vinblastine—Leukopenia—Epirubicin—hematologic cancer	6.65e-06	0.000176	CcSEcCtD
Vinblastine—Constipation—Prednisone—hematologic cancer	6.63e-06	0.000175	CcSEcCtD
Vinblastine—TUBB6—Azacitidine—Clofarabine—hematologic cancer	6.53e-06	0.00809	CbGdCrCtD
Vinblastine—Dizziness—Triamcinolone—hematologic cancer	6.49e-06	0.000172	CcSEcCtD
Vinblastine—JUN—Dexamethasone—Betamethasone—hematologic cancer	6.47e-06	0.00801	CbGdCrCtD
Vinblastine—JUN—Betamethasone—Dexamethasone—hematologic cancer	6.47e-06	0.00801	CbGdCrCtD
Vinblastine—Convulsion—Epirubicin—hematologic cancer	6.44e-06	0.00017	CcSEcCtD
Vinblastine—Nausea—Etoposide—hematologic cancer	6.43e-06	0.00017	CcSEcCtD
Vinblastine—Hypertension—Epirubicin—hematologic cancer	6.42e-06	0.00017	CcSEcCtD
Vinblastine—Feeling abnormal—Prednisone—hematologic cancer	6.39e-06	0.000169	CcSEcCtD
Vinblastine—Asthenia—Dexamethasone—hematologic cancer	6.39e-06	0.000169	CcSEcCtD
Vinblastine—Asthenia—Betamethasone—hematologic cancer	6.39e-06	0.000169	CcSEcCtD
Vinblastine—Ill-defined disorder—Doxorubicin—hematologic cancer	6.38e-06	0.000169	CcSEcCtD
Vinblastine—Anaemia—Doxorubicin—hematologic cancer	6.36e-06	0.000168	CcSEcCtD
Vinblastine—Thrombocytopenia—Methotrexate—hematologic cancer	6.35e-06	0.000168	CcSEcCtD
Vinblastine—Gastrointestinal pain—Prednisone—hematologic cancer	6.34e-06	0.000168	CcSEcCtD
Vinblastine—Nausea—Prednisolone—hematologic cancer	6.34e-06	0.000168	CcSEcCtD
Vinblastine—JUN—Betamethasone—Triamcinolone—hematologic cancer	6.32e-06	0.00783	CbGdCrCtD
Vinblastine—JUN—Dexamethasone—Triamcinolone—hematologic cancer	6.32e-06	0.00783	CbGdCrCtD
Vinblastine—Discomfort—Epirubicin—hematologic cancer	6.25e-06	0.000165	CcSEcCtD
Vinblastine—Vomiting—Triamcinolone—hematologic cancer	6.24e-06	0.000165	CcSEcCtD
Vinblastine—Malaise—Doxorubicin—hematologic cancer	6.2e-06	0.000164	CcSEcCtD
Vinblastine—Vertigo—Doxorubicin—hematologic cancer	6.18e-06	0.000163	CcSEcCtD
Vinblastine—Anorexia—Methotrexate—hematologic cancer	6.18e-06	0.000163	CcSEcCtD
Vinblastine—Leukopenia—Doxorubicin—hematologic cancer	6.15e-06	0.000163	CcSEcCtD
Vinblastine—Headache—Triamcinolone—hematologic cancer	6.15e-06	0.000162	CcSEcCtD
Vinblastine—TUBB6—Azacitidine—Nelarabine—hematologic cancer	6.13e-06	0.0076	CbGdCrCtD
Vinblastine—Abdominal pain—Prednisone—hematologic cancer	6.13e-06	0.000162	CcSEcCtD
Vinblastine—Diarrhoea—Betamethasone—hematologic cancer	6.09e-06	0.000161	CcSEcCtD
Vinblastine—Diarrhoea—Dexamethasone—hematologic cancer	6.09e-06	0.000161	CcSEcCtD
Vinblastine—JUN—Dexamethasone—Prednisone—hematologic cancer	6e-06	0.00743	CbGdCrCtD
Vinblastine—JUN—Betamethasone—Prednisone—hematologic cancer	6e-06	0.00743	CbGdCrCtD
Vinblastine—Convulsion—Doxorubicin—hematologic cancer	5.96e-06	0.000157	CcSEcCtD
Vinblastine—Thrombocytopenia—Epirubicin—hematologic cancer	5.94e-06	0.000157	CcSEcCtD
Vinblastine—Hypertension—Doxorubicin—hematologic cancer	5.94e-06	0.000157	CcSEcCtD
Vinblastine—Dizziness—Betamethasone—hematologic cancer	5.89e-06	0.000156	CcSEcCtD
Vinblastine—Dizziness—Dexamethasone—hematologic cancer	5.89e-06	0.000156	CcSEcCtD
Vinblastine—JUN—Dexamethasone—Prednisolone—hematologic cancer	5.85e-06	0.00725	CbGdCrCtD
Vinblastine—JUN—Betamethasone—Prednisolone—hematologic cancer	5.85e-06	0.00725	CbGdCrCtD
Vinblastine—Nausea—Triamcinolone—hematologic cancer	5.83e-06	0.000154	CcSEcCtD
Vinblastine—Paraesthesia—Methotrexate—hematologic cancer	5.82e-06	0.000154	CcSEcCtD
Vinblastine—Discomfort—Doxorubicin—hematologic cancer	5.78e-06	0.000153	CcSEcCtD
Vinblastine—Anorexia—Epirubicin—hematologic cancer	5.78e-06	0.000153	CcSEcCtD
Vinblastine—Hypersensitivity—Prednisone—hematologic cancer	5.71e-06	0.000151	CcSEcCtD
Vinblastine—Vomiting—Betamethasone—hematologic cancer	5.66e-06	0.00015	CcSEcCtD
Vinblastine—Vomiting—Dexamethasone—hematologic cancer	5.66e-06	0.00015	CcSEcCtD
Vinblastine—Decreased appetite—Methotrexate—hematologic cancer	5.63e-06	0.000149	CcSEcCtD
Vinblastine—Headache—Betamethasone—hematologic cancer	5.58e-06	0.000147	CcSEcCtD
Vinblastine—Headache—Dexamethasone—hematologic cancer	5.58e-06	0.000147	CcSEcCtD
Vinblastine—Asthenia—Prednisone—hematologic cancer	5.56e-06	0.000147	CcSEcCtD
Vinblastine—Pain—Methotrexate—hematologic cancer	5.54e-06	0.000146	CcSEcCtD
Vinblastine—Thrombocytopenia—Doxorubicin—hematologic cancer	5.49e-06	0.000145	CcSEcCtD
Vinblastine—Paraesthesia—Epirubicin—hematologic cancer	5.45e-06	0.000144	CcSEcCtD
Vinblastine—Anorexia—Doxorubicin—hematologic cancer	5.35e-06	0.000141	CcSEcCtD
Vinblastine—Feeling abnormal—Methotrexate—hematologic cancer	5.34e-06	0.000141	CcSEcCtD
Vinblastine—Diarrhoea—Prednisone—hematologic cancer	5.31e-06	0.00014	CcSEcCtD
Vinblastine—Gastrointestinal pain—Methotrexate—hematologic cancer	5.3e-06	0.00014	CcSEcCtD
Vinblastine—Nausea—Betamethasone—hematologic cancer	5.29e-06	0.00014	CcSEcCtD
Vinblastine—Nausea—Dexamethasone—hematologic cancer	5.29e-06	0.00014	CcSEcCtD
Vinblastine—Decreased appetite—Epirubicin—hematologic cancer	5.27e-06	0.000139	CcSEcCtD
Vinblastine—Constipation—Epirubicin—hematologic cancer	5.19e-06	0.000137	CcSEcCtD
Vinblastine—Pain—Epirubicin—hematologic cancer	5.19e-06	0.000137	CcSEcCtD
Vinblastine—Dizziness—Prednisone—hematologic cancer	5.13e-06	0.000136	CcSEcCtD
Vinblastine—Abdominal pain—Methotrexate—hematologic cancer	5.12e-06	0.000135	CcSEcCtD
Vinblastine—Paraesthesia—Doxorubicin—hematologic cancer	5.04e-06	0.000133	CcSEcCtD
Vinblastine—Feeling abnormal—Epirubicin—hematologic cancer	5e-06	0.000132	CcSEcCtD
Vinblastine—Gastrointestinal pain—Epirubicin—hematologic cancer	4.96e-06	0.000131	CcSEcCtD
Vinblastine—Vomiting—Prednisone—hematologic cancer	4.93e-06	0.00013	CcSEcCtD
Vinblastine—Decreased appetite—Doxorubicin—hematologic cancer	4.88e-06	0.000129	CcSEcCtD
Vinblastine—Headache—Prednisone—hematologic cancer	4.86e-06	0.000128	CcSEcCtD
Vinblastine—Constipation—Doxorubicin—hematologic cancer	4.8e-06	0.000127	CcSEcCtD
Vinblastine—Pain—Doxorubicin—hematologic cancer	4.8e-06	0.000127	CcSEcCtD
Vinblastine—Abdominal pain—Epirubicin—hematologic cancer	4.79e-06	0.000127	CcSEcCtD
Vinblastine—TUBB6—Azacitidine—Fludarabine—hematologic cancer	4.79e-06	0.00593	CbGdCrCtD
Vinblastine—Hypersensitivity—Methotrexate—hematologic cancer	4.77e-06	0.000126	CcSEcCtD
Vinblastine—Asthenia—Methotrexate—hematologic cancer	4.65e-06	0.000123	CcSEcCtD
Vinblastine—Feeling abnormal—Doxorubicin—hematologic cancer	4.62e-06	0.000122	CcSEcCtD
Vinblastine—Nausea—Prednisone—hematologic cancer	4.61e-06	0.000122	CcSEcCtD
Vinblastine—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.59e-06	0.000121	CcSEcCtD
Vinblastine—TUBB6—Azacitidine—Cytarabine—hematologic cancer	4.52e-06	0.0056	CbGdCrCtD
Vinblastine—TUBB6—Azacitidine—Gemcitabine—hematologic cancer	4.52e-06	0.0056	CbGdCrCtD
Vinblastine—Hypersensitivity—Epirubicin—hematologic cancer	4.47e-06	0.000118	CcSEcCtD
Vinblastine—Abdominal pain—Doxorubicin—hematologic cancer	4.44e-06	0.000117	CcSEcCtD
Vinblastine—Diarrhoea—Methotrexate—hematologic cancer	4.43e-06	0.000117	CcSEcCtD
Vinblastine—TUBB6—Azacitidine—Cladribine—hematologic cancer	4.41e-06	0.00546	CbGdCrCtD
Vinblastine—Asthenia—Epirubicin—hematologic cancer	4.35e-06	0.000115	CcSEcCtD
Vinblastine—Dizziness—Methotrexate—hematologic cancer	4.29e-06	0.000113	CcSEcCtD
Vinblastine—Diarrhoea—Epirubicin—hematologic cancer	4.15e-06	0.00011	CcSEcCtD
Vinblastine—Hypersensitivity—Doxorubicin—hematologic cancer	4.13e-06	0.000109	CcSEcCtD
Vinblastine—Vomiting—Methotrexate—hematologic cancer	4.12e-06	0.000109	CcSEcCtD
Vinblastine—Headache—Methotrexate—hematologic cancer	4.06e-06	0.000107	CcSEcCtD
Vinblastine—Asthenia—Doxorubicin—hematologic cancer	4.03e-06	0.000106	CcSEcCtD
Vinblastine—Dizziness—Epirubicin—hematologic cancer	4.01e-06	0.000106	CcSEcCtD
Vinblastine—Vomiting—Epirubicin—hematologic cancer	3.86e-06	0.000102	CcSEcCtD
Vinblastine—Nausea—Methotrexate—hematologic cancer	3.85e-06	0.000102	CcSEcCtD
Vinblastine—Diarrhoea—Doxorubicin—hematologic cancer	3.84e-06	0.000101	CcSEcCtD
Vinblastine—Headache—Epirubicin—hematologic cancer	3.8e-06	0.0001	CcSEcCtD
Vinblastine—Dizziness—Doxorubicin—hematologic cancer	3.71e-06	9.81e-05	CcSEcCtD
Vinblastine—Nausea—Epirubicin—hematologic cancer	3.6e-06	9.52e-05	CcSEcCtD
Vinblastine—Vomiting—Doxorubicin—hematologic cancer	3.57e-06	9.43e-05	CcSEcCtD
Vinblastine—Headache—Doxorubicin—hematologic cancer	3.52e-06	9.29e-05	CcSEcCtD
Vinblastine—Nausea—Doxorubicin—hematologic cancer	3.33e-06	8.81e-05	CcSEcCtD
Vinblastine—JUN—Signaling Pathways—IL2RA—hematologic cancer	4.54e-07	1.46e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ABCB1—hematologic cancer	4.51e-07	1.45e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TERT—hematologic cancer	4.49e-07	1.44e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PIK3CB—hematologic cancer	4.48e-07	1.44e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MTOR—hematologic cancer	4.48e-07	1.44e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD4—hematologic cancer	4.47e-07	1.44e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SPHK1—hematologic cancer	4.47e-07	1.44e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CD80—hematologic cancer	4.47e-07	1.44e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.46e-07	1.43e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—KIT—hematologic cancer	4.46e-07	1.43e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—MTHFR—hematologic cancer	4.45e-07	1.43e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SLC22A1—hematologic cancer	4.43e-07	1.42e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CRABP1—hematologic cancer	4.43e-07	1.42e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTPN11—hematologic cancer	4.38e-07	1.41e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PDGFB—hematologic cancer	4.38e-07	1.41e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—NCOR1—hematologic cancer	4.38e-07	1.41e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GSTM1—hematologic cancer	4.38e-07	1.41e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CD—hematologic cancer	4.37e-07	1.4e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—HRAS—hematologic cancer	4.34e-07	1.39e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ALOX5—hematologic cancer	4.32e-07	1.39e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.32e-07	1.39e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—ALB—hematologic cancer	4.32e-07	1.39e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	4.29e-07	1.38e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TSC2—hematologic cancer	4.28e-07	1.38e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CREB1—hematologic cancer	4.25e-07	1.36e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—MTAP—hematologic cancer	4.24e-07	1.36e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CDKN1B—hematologic cancer	4.21e-07	1.35e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—BRAF—hematologic cancer	4.19e-07	1.35e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NUP98—hematologic cancer	4.18e-07	1.34e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CRABP1—hematologic cancer	4.18e-07	1.34e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	4.18e-07	1.34e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IL6—hematologic cancer	4.15e-07	1.33e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IL6R—hematologic cancer	4.14e-07	1.33e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CREBBP—hematologic cancer	4.14e-07	1.33e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL1B—hematologic cancer	4.13e-07	1.33e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3R1—hematologic cancer	4.13e-07	1.33e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—FGFR3—hematologic cancer	4.12e-07	1.32e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL2—hematologic cancer	4.12e-07	1.32e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAPK14—hematologic cancer	4.08e-07	1.31e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ALOX5—hematologic cancer	4.07e-07	1.31e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ADCY7—hematologic cancer	4.06e-07	1.3e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NCOA3—hematologic cancer	4.06e-07	1.3e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NUP214—hematologic cancer	4.03e-07	1.3e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ESR1—hematologic cancer	4e-07	1.29e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—FN1—hematologic cancer	3.95e-07	1.27e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ABCG2—hematologic cancer	3.95e-07	1.27e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—MTR—hematologic cancer	3.95e-07	1.27e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MAP2K1—hematologic cancer	3.95e-07	1.27e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NUP98—hematologic cancer	3.94e-07	1.27e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3CD—hematologic cancer	3.92e-07	1.26e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.92e-07	1.26e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—BAD—hematologic cancer	3.91e-07	1.25e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NFKBIA—hematologic cancer	3.91e-07	1.25e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CDKN1A—hematologic cancer	3.88e-07	1.25e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PTEN—hematologic cancer	3.87e-07	1.24e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ENO2—hematologic cancer	3.87e-07	1.24e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—MTHFR—hematologic cancer	3.87e-07	1.24e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NOTCH1—hematologic cancer	3.87e-07	1.24e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—AKT1—hematologic cancer	3.83e-07	1.23e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NCOA3—hematologic cancer	3.83e-07	1.23e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ADCY7—hematologic cancer	3.83e-07	1.23e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CB—hematologic cancer	3.81e-07	1.22e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NUP214—hematologic cancer	3.8e-07	1.22e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MAPK8—hematologic cancer	3.79e-07	1.22e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CD80—hematologic cancer	3.79e-07	1.22e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CG—hematologic cancer	3.78e-07	1.21e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KIT—hematologic cancer	3.78e-07	1.21e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—FHL2—hematologic cancer	3.78e-07	1.21e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTT1—hematologic cancer	3.76e-07	1.21e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—FGF2—hematologic cancer	3.75e-07	1.21e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CG—hematologic cancer	3.74e-07	1.2e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—MTR—hematologic cancer	3.72e-07	1.2e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ABCG2—hematologic cancer	3.72e-07	1.2e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTPN11—hematologic cancer	3.72e-07	1.19e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—AGRN—hematologic cancer	3.7e-07	1.19e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3R1—hematologic cancer	3.7e-07	1.19e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—EP300—hematologic cancer	3.69e-07	1.19e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SDC1—hematologic cancer	3.67e-07	1.18e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ENO2—hematologic cancer	3.65e-07	1.17e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.65e-07	1.17e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CREB1—hematologic cancer	3.6e-07	1.16e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—JAK2—hematologic cancer	3.6e-07	1.16e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—SRC—hematologic cancer	3.59e-07	1.15e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—BRAF—hematologic cancer	3.56e-07	1.14e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTT1—hematologic cancer	3.54e-07	1.14e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCL2—hematologic cancer	3.52e-07	1.13e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.52e-07	1.13e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MDM2—hematologic cancer	3.51e-07	1.13e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL6R—hematologic cancer	3.51e-07	1.13e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—IDH2—hematologic cancer	3.51e-07	1.13e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HMMR—hematologic cancer	3.51e-07	1.13e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CREBBP—hematologic cancer	3.51e-07	1.13e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—STAT3—hematologic cancer	3.46e-07	1.11e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CREBBP—hematologic cancer	3.46e-07	1.11e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SDC1—hematologic cancer	3.46e-07	1.11e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—NRAS—hematologic cancer	3.46e-07	1.11e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MTOR—hematologic cancer	3.42e-07	1.1e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3CB—hematologic cancer	3.42e-07	1.1e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CD4—hematologic cancer	3.41e-07	1.1e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAP2K1—hematologic cancer	3.35e-07	1.08e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CD—hematologic cancer	3.33e-07	1.07e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MAPK3—hematologic cancer	3.31e-07	1.06e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.3e-07	1.06e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.29e-07	1.06e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTEN—hematologic cancer	3.29e-07	1.06e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CD—hematologic cancer	3.28e-07	1.05e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CG—hematologic cancer	3.25e-07	1.04e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ALB—hematologic cancer	3.24e-07	1.04e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ACP5—hematologic cancer	3.21e-07	1.03e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CA9—hematologic cancer	3.21e-07	1.03e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CDKN1B—hematologic cancer	3.21e-07	1.03e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—FGF2—hematologic cancer	3.18e-07	1.02e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.17e-07	1.02e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3R1—hematologic cancer	3.14e-07	1.01e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—EP300—hematologic cancer	3.14e-07	1.01e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CD44—hematologic cancer	3.12e-07	1e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NQO1—hematologic cancer	3.12e-07	1e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3R1—hematologic cancer	3.1e-07	9.96e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—JAK2—hematologic cancer	3.05e-07	9.8e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—IDH1—hematologic cancer	3.02e-07	9.7e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CREBBP—hematologic cancer	3.02e-07	9.69e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.99e-07	9.59e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—TXN—hematologic cancer	2.99e-07	9.59e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.99e-07	9.59e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MDM2—hematologic cancer	2.98e-07	9.57e-06	CbGpPWpGaD
Vinblastine—JUN—Immune System—KRAS—hematologic cancer	2.97e-07	9.55e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CDKN1A—hematologic cancer	2.96e-07	9.51e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYCS—hematologic cancer	2.95e-07	9.49e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTEN—hematologic cancer	2.95e-07	9.49e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CD44—hematologic cancer	2.94e-07	9.45e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NQO1—hematologic cancer	2.94e-07	9.45e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.94e-07	9.43e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.92e-07	9.38e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MTOR—hematologic cancer	2.9e-07	9.31e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CB—hematologic cancer	2.9e-07	9.31e-06	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CB—hematologic cancer	2.86e-07	9.19e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CD—hematologic cancer	2.86e-07	9.19e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ALB—hematologic cancer	2.82e-07	9.07e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—EP300—hematologic cancer	2.82e-07	9.05e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.81e-07	9.02e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYCS—hematologic cancer	2.78e-07	8.94e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.77e-07	8.89e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—SRC—hematologic cancer	2.74e-07	8.8e-06	CbGpPWpGaD
Vinblastine—JUN—Immune System—PIK3CA—hematologic cancer	2.73e-07	8.78e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.73e-07	8.77e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.73e-07	8.77e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CDKN1B—hematologic cancer	2.72e-07	8.74e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3R1—hematologic cancer	2.7e-07	8.67e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CASP3—hematologic cancer	2.67e-07	8.56e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL2—hematologic cancer	2.66e-07	8.55e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.66e-07	8.55e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—STAT3—hematologic cancer	2.64e-07	8.48e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NRAS—hematologic cancer	2.63e-07	8.46e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTP1—hematologic cancer	2.6e-07	8.36e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCND1—hematologic cancer	2.59e-07	8.33e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NUP98—hematologic cancer	2.58e-07	8.28e-06	CbGpPWpGaD
Vinblastine—JUN—Immune System—HRAS—hematologic cancer	2.53e-07	8.12e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MAPK3—hematologic cancer	2.52e-07	8.11e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CDKN1A—hematologic cancer	2.51e-07	8.06e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTEN—hematologic cancer	2.5e-07	8.04e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.5e-07	8.04e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.5e-07	8.04e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CB—hematologic cancer	2.49e-07	8.01e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NUP214—hematologic cancer	2.48e-07	7.98e-06	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTEN—hematologic cancer	2.47e-07	7.94e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MYC—hematologic cancer	2.45e-07	7.88e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.45e-07	7.88e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAPK8—hematologic cancer	2.45e-07	7.87e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TGFB1—hematologic cancer	2.45e-07	7.86e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.43e-07	7.82e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—MTR—hematologic cancer	2.43e-07	7.82e-06	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL6—hematologic cancer	2.42e-07	7.77e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NCOR1—hematologic cancer	2.39e-07	7.69e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTM1—hematologic cancer	2.39e-07	7.69e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—EP300—hematologic cancer	2.39e-07	7.67e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ENO2—hematologic cancer	2.39e-07	7.67e-06	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—EP300—hematologic cancer	2.36e-07	7.58e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.32e-07	7.46e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SRC—hematologic cancer	2.32e-07	7.46e-06	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CA—hematologic cancer	2.32e-07	7.46e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.31e-07	7.44e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—KRAS—hematologic cancer	2.27e-07	7.28e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SDC1—hematologic cancer	2.26e-07	7.27e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—VEGFA—hematologic cancer	2.26e-07	7.27e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.26e-07	7.24e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.26e-07	7.24e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—STAT3—hematologic cancer	2.24e-07	7.19e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NRAS—hematologic cancer	2.23e-07	7.18e-06	CbGpPWpGaD
Vinblastine—JUN—Immune System—AKT1—hematologic cancer	2.23e-07	7.17e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTEN—hematologic cancer	2.15e-07	6.92e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAPK3—hematologic cancer	2.14e-07	6.87e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—MTHFR—hematologic cancer	2.12e-07	6.79e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3CA—hematologic cancer	2.08e-07	6.69e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MYC—hematologic cancer	2.08e-07	6.69e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TGFB1—hematologic cancer	2.08e-07	6.67e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—EP300—hematologic cancer	2.05e-07	6.6e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.99e-07	6.4e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HRAS—hematologic cancer	1.93e-07	6.19e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NQO1—hematologic cancer	1.92e-07	6.18e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CD44—hematologic cancer	1.92e-07	6.18e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KRAS—hematologic cancer	1.92e-07	6.18e-06	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—AKT1—hematologic cancer	1.9e-07	6.09e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IL6—hematologic cancer	1.84e-07	5.93e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYCS—hematologic cancer	1.82e-07	5.85e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.81e-07	5.81e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.78e-07	5.71e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CA—hematologic cancer	1.77e-07	5.68e-06	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CA—hematologic cancer	1.74e-07	5.6e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TP53—hematologic cancer	1.71e-07	5.49e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—AKT1—hematologic cancer	1.7e-07	5.47e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.67e-07	5.38e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CREBBP—hematologic cancer	1.65e-07	5.29e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HRAS—hematologic cancer	1.63e-07	5.25e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.6e-07	5.15e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL6—hematologic cancer	1.56e-07	5.03e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.56e-07	5.02e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.55e-07	4.99e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ALB—hematologic cancer	1.54e-07	4.95e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CA—hematologic cancer	1.52e-07	4.88e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.52e-07	4.88e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.48e-07	4.74e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.47e-07	4.74e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.47e-07	4.74e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.47e-07	4.73e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ALB—hematologic cancer	1.45e-07	4.67e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—AKT1—hematologic cancer	1.44e-07	4.64e-06	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—AKT1—hematologic cancer	1.43e-07	4.58e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.39e-07	4.47e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.36e-07	4.37e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.3e-07	4.19e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.28e-07	4.12e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—AKT1—hematologic cancer	1.24e-07	3.99e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTEN—hematologic cancer	1.18e-07	3.78e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—EP300—hematologic cancer	1.12e-07	3.6e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.11e-07	3.56e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.09e-07	3.52e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—EP300—hematologic cancer	1.06e-07	3.4e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.02e-07	3.26e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	9.63e-08	3.09e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ALB—hematologic cancer	9.5e-08	3.05e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	9.09e-08	2.92e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	8.39e-08	2.69e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CA—hematologic cancer	8.3e-08	2.67e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	7.82e-08	2.51e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTEN—hematologic cancer	7.25e-08	2.33e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—EP300—hematologic cancer	6.91e-08	2.22e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—AKT1—hematologic cancer	6.78e-08	2.18e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—AKT1—hematologic cancer	6.39e-08	2.05e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.11e-08	1.64e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—AKT1—hematologic cancer	4.18e-08	1.34e-06	CbGpPWpGaD
